GainersToday.com
GainersToday.com, Tracking Stock Market Picks
Enter Symbol:
 
Evertec Inc. Common Stock (EVTC) [hlAlert]

Evotec AG (Evotec) is a drug discovery and development company focused on small molecule therapeutics. Evotec is developing treatments for diseases in the areas of neuroscience, pain, and inflammation. Evotec?s portfolio comprises five clinical drug candidates: EVT 101, a subtype selective NMDA receptor antagonist with potential for the treatment
of Alzheimer?s disease, pain and depression, EVT 201, a partial positive allosteric modulator (pPAM) of the GABAA receptor complex for the treatment of insomnia, EVT 302, a MAO-B inhibitor in development for smoking cessation, a P2X7 antagonist for the treatment of inflammatory diseases, and a small molecule vanilloid receptor (VR1) antagonist for the treatment of pain in partnership with Pfizer. Evotec?s late stage preclinical research programs focus on EVT 103, a back-up compound to EVT 101, H3 antagonists for the treatment of cognitive disorders and/or sleep, as well as antagonists for the purinergic receptor P2X3 for the treatment of pain.
.
( Total: 9 Current Stock Recommendations )
Evertec Inc. Common Stock   (9)
Hold 33% Buy 67%
Related companies
China Biologic ...   (4)
Buy 100%
BioSpecifics ...   (5)
Buy 100%
PROLOR Biotech, Inc.   (5)
Buy 100%
Opko Health Inc   (2)
Buy 100%
Flamel Technologies ...   (8)
Buy 100%
Aeterna Zentaris, ...   (12)
Buy 100%
Lannett Co Inc   (4)
Buy 100%
Anika Therapeutics ...   (4)
Buy 100%
Emergent ...   (6)
Buy 100%
Insys Therapeutics ...   (4)
Buy 100%
Show  

Date (ET)MemberRatingYTD
Gains
 
5/7/2013  
Buy
  
5/7/2013  
Buy
  
5/7/2013  
Buy
  
5/7/2013  
Buy
  
5/7/2013  
Buy
  
8/8/2013  
Hold
  
9/16/2013  
Buy
  
11/24/2014  
Hold
  
11/5/2015  
Hold
  

* As of 8/27/2015 12:00 AM
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy